COLL - Collegium Pharmaceutical, Inc.
NEXT EARNINGS:
Feb 26, 2026
(in 1 day)
EPS Est: $2.20
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$58.00
DETAILS
HIGH:
$60.00
LOW:
$56.00
MEDIAN:
$58.00
CONSENSUS:
$58.00
UPSIDE:
28.40%
Market Cap:
1.43B
Volume:
226,822
Avg Volume:
472,421
52 Week Range:
23.23-50.787
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Beta:
0.65
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
357
IPO Date:
2015-05-07
EPS (TTM):
2.14
P/E Ratio:
13.36
Revenue (TTM):
631.45M
Total Assets:
1.66B
Total Debt:
859.30M
Cash & Equiv:
70.56M
Rev Growth (5Y):
16.3%
EPS Growth (5Y):
28.7%
FCF Growth (5Y):
56.9%
ROCE:
15.0%
Debt/Equity:
3.75
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-06 | $2.25 | $1.88 | +19.7% | $209.4M | $206.2M | +1.6% |
| 2025-05-08 | $1.49 | $1.43 | +4.2% | $177.8M | $173.1M | +2.7% |
| 2025-02-27 | $1.77 | $1.54 | +14.9% | $181.9M | $179.7M | +1.3% |
| 2024-11-07 | $1.61 | $1.66 | -3.0% | $159.3M | $179.5M | -11.2% |
| 2024-08-08 | $1.62 | $1.56 | +3.8% | $145.3M | $143.9M | +0.9% |
| 2024-05-09 | $1.45 | $1.49 | -2.7% | $144.9M | $146.9M | -1.4% |
| 2024-02-22 | $1.58 | $1.33 | +18.8% | $149.7M | $148.0M | +1.2% |
| 2023-11-07 | $1.34 | $1.24 | +8.1% | $136.7M | $138.5M | -1.3% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 631.45M | 566.77M | 463.93M | 276.87M | 310.02M | 296.70M | 280.41M | 28.48M | 1.71M | 0 | 0 | 0 |
| Net Income | 69.19M | 48.16M | (25.00M) | 71.52M | 26.75M | (22.72M) | (39.13M) | (74.86M) | (94.18M) | (27.25M) | (17.92M) | (16.20M) |
| EPS | 2.14 | 1.60 | -0.74 | 2.05 | 0.78 | -0.24 | -1.19 | -2.47 | -3.88 | -2.01 | -2.40 | -2.17 |
| Total Assets | 1.66B | 1.14B | 1.17B | 692.08M | 643.84M | 306.30M | 291.25M | 135.57M | 162.02M | 97.72M | 5.09M | 9.03M |
| Total Debt | 859.30M | 674.28M | 709.17M | 258.75M | 266.58M | 21.59M | 11.50M | 1.48M | 4.15M | 6.81M | 13.01M | 973,000 |
| Cash & Equivalents | 70.56M | 238.95M | 173.69M | 186.43M | 174.12M | 170.02M | 146.63M | 118.70M | 153.22M | 95.70M | 1.63M | 7.55M |
| Operating Cash Flow | 204.98M | 274.75M | 124.23M | 103.56M | 93.94M | 27.78M | 169.39M | (67.02M) | (75.05M) | (21.57M) | (17.95M) | (16.53M) |
| Free Cash Flow | 203.33M | 274.29M | 122.61M | 101.61M | (279.83M) | 21.34M | 145.04M | (68.01M) | (78.03M) | (21.93M) | (17.95M) | (16.74M) |
| FCF per Share | 6.30 | 8.13 | 3.62 | 2.91 | -8.13 | 0.64 | 4.41 | -2.25 | -3.22 | -1.62 | -2.40 | -2.24 |
| Book Value | 228.84M | 195.43M | 194.84M | 202.93M | 186.03M | 87.43M | 91.58M | 104.08M | 134.91M | 85.07M | (12.24M) | 5.58M |
| Cash & ST Investments | 162.76M | 310.55M | 173.69M | 186.43M | 174.12M | 170.02M | 146.63M | 118.70M | 153.22M | 95.70M | 1.63M | 7.55M |
| ROC Equity | 0.30 | 0.25 | -0.13 | 0.35 | 0.14 | -0.26 | -0.43 | -0.72 | -0.70 | -0.32 | N/A | -2.90 |